“Advances in Chemotherapy-Induced Peripheral Neuropathy Research” Facebook Chat on April 17th Draws Several Hundred Participants

Updated April 19th, 2013

           professional head shot 2012_asco_joanna_bre#39D4A6.jpg

Share your experiences with chemotherapy-induced peripheral neuropathy: TAKE OUR POLL! 

Related articles:
- “Ask the Doctor” column
addressing chemotherapy-
induced neuropathy

-Social Media’s Leading Physician Voice,, Brings Attention to Cancer-Related Neuropathies;

- Proceedings of The Neuropathy Association’s Neuropathy Summit-Physicians Conference: A Supplement to the Journal of the Peripheral Nervous System

Support Your #1 Cause: The Fight Against Neuropathy!

On April 17th, Dr. Joanna Brell hosted a "chat" event on The Neuropathy Association's Facebook page, focusing on the advances in chemotherapy-induced peripheral neuropathy research.

Missed this Facebook Chat? Sign up to receive a free copy of the transcript once it is published!

Over 2,000 patients and their family members and friends got together virtually for this Chat to discuss a common long-term health effect impacting a third of cancer survivors: neuropathy, resulting from the tumor compressing on and/or infiltrating the peripheral nerves as well as from the cancer therapies (surgery, chemotherapy, or radiation. For these patients, neuropathy and neuropathic pain is the “price of survival” that severely compromises quality of life and daily function. 

Our educational Facebook Chat events offer a unique opportunity for you to hear from and ask questions of a health care expert in the field as well as of your peers—patients and caregivers—who are battling neuropathy. In addition, they emphasize that living well with neuropathy is possible with early diagnosis, symptom management, and regular follow-ups, but it requires active engagement by the patient in his/her own medical care along with the aid of an array of resources—limited as they are—that do currently exist.

Dr. Joanna M. Brell is a program director at the National Cancer Institute (NCI) and is charged with promoting basic and clinical research regarding anti-cancer therapy toxicities and cancer symptoms. Her research interests are in therapy-associated peripheral neuropathy and cardiac toxicity. Before joining the NCI, Dr. Brell was assistant professor in the Division of Hematology/Oncology at the Case School of Medicine and a medical oncologist with the Case Comprehensive Cancer Center at University Hospitals. Dr. Brell received her medical degree from the University of Texas Medical School at Houston, Texas. She completed an Internal Medicine residency and a Hematology/Oncology fellowship at the Cleveland Clinic Foundation in Cleveland, Ohio. She is board certified in Internal Medicine, Medical Oncology, and Hematology.

A special thanks to Dr. Brell for giving her time and expertise to speak with our community!


All active news articles

Home / Contact UsPeripheral Neuropathy Site Map / Disclaimer
© 2015 The Neuropathy Association / 110 W. 40th Street, Suite 1804 / New York, NY 10018 / 212-692-0662


- +